The biggest biotech investments of November 2023
Welcome to the 42 new subscribers who joined our LinkedIn newsletter last week ?? If not done yet, subscribe to join the 4,978 fans of the Pick of the Week!
So, which biotech companies managed to bag the biggest private investment rounds in November 2023?
Well, the top three rounds went to the companies Cambrian , Terremoto Biosciences , and VectorY , with oncology and CNS players bringing in the most funding overall.
But it's worth noting that, as we head towards the December holiday season, biotech fundraising seems to be drying up a bit compared to previous months.
In fact, the Asia-Pacific region didn't see any major funding rounds take place last month.
To find out more, read the full article: "The biggest private biotech investments in November 2023"
?? More noteworthy articles from this week:
领英推荐
CASGEVY - developed for the treatment of sickle cell disease and beta-thalassemia - has become the world's first approved CRISPR-based therapy, as it recently gained approval from the MHRA in the U.K. and the FDA in the U.S.
As the biopharma community met in Munich, Germany, for BIO-Europe 2023 last month - with a turnout of nearly 6,000 participants and more than 150 exhibitors - we take a look at the top ten highlights from the event.
Patents are guardians of groundbreaking research and development for biotech companies, safeguarding the investment poured into research, as well as facilitating collaboration and investment.
In the UAE, Dubai stands out as the primary hub for life science companies - with more than 350 companies calling the city their home - and here we take a look in more detail at five Dubai-based biopharma companies we think you should know about.
??Enjoying these articles??Never miss a single publication of Labiotech by becoming a part of our community! Click here to join our mailing list.